Access the full text.
Sign up today, get DeepDyve free for 14 days.
Very few individuals have so profoundly influenced the field of surgical oncology as has Dr. Bernard Fisher, who died on October 16, 2019, at the age of 101. Fisher is widely known for his work on the treatment and prevention of primary breast cancer, where he championed breast-conserving surgery, the use adjuvant systemic therapies, and chemoprevention (i.e., the use of anti-estrogens to prevent breast cancer). However, Fisher’s impact extends far beyond the field of surgical oncology. He questioned the value of observational studies in clinical decision-making and emphasized that large randomized trials with unambiguous endpoints (i.e., all-cause mortality) should form the basis for patient management.
"Indian Journal of Surgical Oncology" – Springer Journals
Published: Mar 13, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.